Healthy adults
Conditions
Interventions
Daily ingestion of 200 mL of juice containing active ingredient for 12 weeks
Daily ingestion of 200 mL of juice not containing active ingredient for 12 weeks
Sponsors
Leverage Brain Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects who agree to participate in this study with a written informed consent 2. Subjects whose HDL-cholesterol level is >=35 mg/dL and <=60 mg/dL
Exclusion criteria
Exclusion criteria: 1. Subjects who are under physician's advice, treatment, and/or medication for dyslipidemia and/or diabetes. 2. Subjects with familial hypercholesterolemia. 3. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 4. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 5. Subjects who have had allergic reactions to drugs or foods especially based on test food, Japanese cedar, Japanese cypress, or grass. 6. Subjects who regularly use medicines, health foods, and supplements. 7. Subjects who regularly take foods containing ingredients of test food. 8. Heavy smokers. 9. Alcohol addicts. 10. Subjects with disordered lifestyle. 11. Subjects with anemia. 12. Pre- or post-menopausal women complaining of obvious physical changes. 13. Pregnant or lactating women, women who expect to be pregnant during this study or may be pregnant. 14. Subjects who currently participate in other clinical trials or participated within the last 4 weeks prior to the current study. 15. Subjects who regularly exercise. 16. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HDL-cholesterol level | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol level, LDL-cholesterol level, triglyceride level, serum active ingredient level, skin carotenoid level | — |
Countries
Japan
Contacts
Public ContactShigeru Imai
Leverage Brain Inc. Clinical Trial Department
Outcome results
None listed